Skip to main content

Prefilled Syringes Market Size Expected to Reach USD 15.20 billion, exhibiting a CAGR of 10.6% by 2029

As per the report by Fortune Business Insights, the global Prefilled Syringes Market size is projected to reach USD 15.20 billion in 2029, at a CAGR of 10.6 % during the forecast period, 2022-2029

Pune, India, April 19, 2023 (GLOBE NEWSWIRE) — The global Prefilled Syringes Market size was USD 6.60 billion in 2021. The market is expected to grow from USD 7.51 billion in 2022 to USD 15.20 billion by 2029, exhibiting a CAGR of 10.6 % during the forecast period.

Industry Development:

  • Becton, Dickinson and Company partnered with Aptar Pharma and launched BD SCF PremiumCoat Plunger Stopperade to support biologics injection with pre-filled syringe.
  • Cumberland Pharmaceuticals launched RediTrex, a methotrexate prefilled syringe.


Request a Free Sample Copy of the Research Report:

https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/prefilled-syringes-market-101946


Report Scope

Report CoverageDetails
Forecast Period2022 to 2029
Forecast Period 2022 to 2029 CAGR10.6%
2029 Value ProjectionUSD 15.20 billion
Base Year2021
Market Size in 2021USD 6.60 billion
Historical Data2018-2020
No. of Pages188


Key Takeaways from the Prefilled Syringes Market:

  • The glass segment held the largest market share in prefilled syringes in 2020.
  • The market is segmented into complete syringe sets and components & accessories based on products.
  • Europe was the leading region in the global market in 2021, with a revenue of USD 2.66 billion.

Driving factor:

The demand for biological drugs is increasing worldwide, and innovations in prefilled products and injectable delivery systems are expected to drive the growth of the prefilled syringes market. Additionally, the growing incidence of autoimmune diseases, cancer, and other chronic conditions is expected to fuel the demand for biological drugs and stimulate market growth.

The increasing adoption of prefilled syringes for self-administration of parenteral drugs is expected to be a significant driver of market growth in the near future. The ease and convenience of the administration process offer numerous advantages that are likely to increase the demand for the product in the years ahead.


Browse Complete Report Details: https://www.fortunebusinessinsights.com/industry-reports/prefilled-syringes-market-101946


Segmentation:

The market is divided into several segments based on various factors. The materials segment is bifurcated into plastic and glass. The closing system segment is trifurcated into a luer lock form system, luer cone system, and staked needle system. The product segment is divided into components & accessories and a complete syringe set. The design segment is segmented into multiple chambers, double-chamber, and single chambers. The end-user segment is fragmented into contract research & manufacturing organizations, pharmaceutical & biotechnology companies, and others. Geographically, the market is classified into the Middle East & Africa, Latin America, Europe, Asia Pacific, and North America.

Regional insights:

  • The dominant market share in the global prefilled syringes market is projected to be held by Europe. The increasing use of biologics by a growing population of patients with chronic diseases is expected to drive market growth in the region. Additionally, the presence of key players in the region is expected to stimulate market growth through product development.
  • North America is expected to rank second in the global market share. The increasing number of patients suffering from chronic diseases such as rheumatoid arthritis and diabetes is expected to drive demand for prefilled syringes and foster market growth.
  • Swift growth is expected in the Asia Pacific region due to the rising incidence of chronic diseases. The expanding patient population and growing use of prefilled syringes are expected to support market growth in the Asia Pacific.
  • The Middle East & Africa and Latin America are predicted to exhibit slow growth due to low product penetration and awareness.

Competitive Landscape


Quick Buy – https://www.fortunebusinessinsights.com/checkout-page/101946


The Report Lists the Key Companies in the Prefilled Syringes Market:

  • BD (U.S.)
  • Gerresheimer AG (Germany)
  • SCHOTT AG (Germany)
  • West Pharmaceutical Services Inc. (U.S.)
  • Helvoet Rubber & Plastic Technologies BV (Netherlands)
  • Nipro PharmaPackaging International (Belgium)
  • AptarGroup, Inc. (U.S.)
  • Terumo Corporation (Japan)

Some major points from Table of Content:

  • Introduction
    • Research Scope
    • Market Segmentation
    • Research Methodology
    • Definitions and Assumptions
  • Executive Summary
  • Market Dynamics
    • Market Drivers
    • Market Restraints
    • Market Opportunities
  • Key Insights
    • Regulatory Scenario by Key Countries/Key Region
    • Overview of Secondary Prefilled Containers such as Auto-injectors, Pens, etc.
    • Prefilled Syringes Key Market Trends
    • Overview of Contract Research and Manufacturing Service Providers for Prefilled Syringes
    • Key Industry Developments (Mergers, Acquisitions, Strategic Partnerships, Collaborations, etc.)
    • Impact of COVID-19 on Prefilled Syringes Market
  • Global Prefilled Syringes Market Analysis, Insights and Forecast, 2018-2029
    • Key Findings / Summary
    • Market Analysis, Insights and Forecast – By Material
      • Glass
      • Plastic
    • Market Analysis, Insights and Forecast – By Closing System
      • Staked Needle System
      • Luer Cone System
      • Luer Lock Form System
    • Market Analysis, Insights and Forecast – By Product
      • Complete Syringe Set
      • Components & Accessories (Backstops, Plunger Stoppers, and Plunger Rods)
    • Market Analysis, Insights and Forecast – By Design
      • Single-chamber
      • Double-chamber
      • Multiple-chamber
    • Market Analysis, Insights and Forecast – By End User
      • Pharmaceutical & Biotechnology Companies
      • Contract Research & Manufacturing Organizations
      • Others
    • Market Analysis, Insights and Forecast – By Region
      • North America
      • Europe
      • Asia Pacific
      • Latin America
      • Middle East & Africa
  • North America Prefilled Syringes Market Analysis, Insights and Forecast, 2018-2029
    • Key Findings / Summary
    • Market Analysis – By Material
      • Glass
      • Plastic
    • Market Analysis – By Closing System
      • Staked Needle System
      • Luer Cone System
      • Luer Lock Form System
    • Market Analysis – By Product
      • Complete Syringe Set
      • Components & Accessories (Backstops, Plunger Stoppers, and Plunger Rods)
    • Market Analysis – By Design
      • Single-chamber
      • Double-chamber
      • Multiple Chamber
    • Market Analysis, Insights and Forecast – By End User
      • Pharmaceutical & Biotechnology Companies
      • Contract Research & Manufacturing Organizations
      • Others
    • Market Analysis – By Country
      • U.S.
        • By Product
      • Canada
        • By Product

TOC Continued…


Have Any Query? Ask Our Experts: https://www.fortunebusinessinsights.com/enquiry/speak-to-analyst/prefilled-syringes-market-101946


Related Links:

Injectable Drug Delivery Market Size, Share, Growth Industry Report, 2020-2027

Diabetes Treatment Devices Market Share, Size, Demand and Forecast

Vitreoretinal Surgery Devices Market Size, Share, Growth Industry Report

U.S. Biosimilars Market Share, Size, Demand and Forecast 2022-2029

Clinical Trials Market Size, Share, Growth Industry Report

About Us:

Fortune Business Insights™ delivers accurate data and innovative corporate analysis, helping organizations of all sizes make appropriate decisions. We tailor novel solutions for our clients, assisting them to address various challenges distinct to their businesses. Our aim is to empower them with holistic market intelligence, providing a granular overview of the market they are operating in.

Contact Us:

Fortune Business Insights™ Pvt. Ltd.

Pune – 411045, Maharashtra, India.

Phone:

US :+1 424 253 0390

UK : +44 2071 939123

APAC : +91 744 740 1245

Email: sales@fortunebusinessinsights.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.